Trends in PCI - PCI vs. Thrombolysis: The Debate

ABOUT DATAMONITOR HEALTHCARE

• About the Cardiovascular pharmaceutical analysis team

EXECUTIVE SUMMARY

• Introduction
• Scope and coverage of this Brief
• Key findings about the topic

PERCUTANEOUS CORONARY INTERVENTION MARKET DYNAMICS

• The PCI market
• Evolution to drug-eluting stents
• Success of the drug-eluting stent
• Cost effectiveness of drug-eluting stents
• The drug-eluting stent gold standard
  • Cypher
  • Taxus
• Latest clinical trial update
  • Taxus
  • Cypher
• Safety and side-effect issues with drug-eluting stents
  • Stents and the use of adjunctive therapy
• Reimbursement update
  • UK
  • France
  • Belgium
• New entrants
  • Biodegradable stent technology
• Future market

PCI VS. THROMBOLYSIS

• PCI is the way forward
• Time-to-needle
• Remoteness and transfer time
• Pre-hospital thrombolysis: the next step?
• New developments
• Conclusion

APPENDIX

• Contributing experts
• Bibliography
  • Other Clinical Data
  • Research methodology
  • Disclaimer
• List of Tables
  • Table 1: Comparison of cost of bare-metal and drug-eluting stents
  • Table 2: Drug-eluting stents marketed or in development
  • Table 3: Price comparisons of adjunctive therapies
• List of Figures
  • Figure 1: Advances in PCI have improved patient outcomes (US data)
  • Figure 2: Drug-eluting stents have further improved patient outcomes
  • Figure 3: Breakdown of treatment time and mortality rate